Drug Approval | December 21, 2021
Shilpa Medicare launch Prucalshil for treatment of constipation
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
The capsules are the generic version of the reference listed drug Mycobutin
It is indicated for the treatment of patients with acromegaly and Gastroenteropancreatic Neuroendocrine Tumours
The surgery was helmed by Prof. Dr. Vishwanath Pai, Sr. Consultant, Department of Minimally Invasive Surgery, Prashanth Hospitals, Velachery
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
Sputnik Light as a booster significantly increases virus-neutralizing activity against Omicron based on sera 2-3 months after revaccination and is a universal booster to other vaccines inducing stronger antibody and T-cell response
2022 is going to be the year of opportunities and innovations from the medical industry in India
The medicine is the first and only oral MET inhibitor to receive CHMP positive opinion in Europe for adult patients with advanced NSCLC harbouring alterations leading to METex14 skipping
The company will collaborate with U.S.-based colleagues to help life sciences companies improve commercial effectiveness
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
Subscribe To Our Newsletter & Stay Updated
